Biotech Group Acquisition Corp

Biotech Group Acquisition Corp (Nasdaq: BGAC) is a blank check company formed to pursue a business combination in the life sciences and biotechnology sector. The company filed an amended registration statement (S-1/A) with the SEC on May 26, 2022, under accession number 0001213900-22-029571, reflecting an active IPO process targeting the 2022 class of SPAC listings. Sponsored by Biotech Group Holdings LLC, the vehicle was structured to identify and merge with an emerging or growth-stage biotechnology target. BGAC represents one of several sector-focused life sciences SPACs that came to market during the evolving 2022 SPAC landscape. Sign up at SpacDesk for full filing history, sponsor details, and real-time deal status on BGAC and hundreds of other active and historical SPACs.